申请人:Chiesi Farmaceutici S.p.A.
公开号:US20180112202A1
公开(公告)日:2018-04-26
The present invention relates to a process for purifying recombinant human Galactocerebroside β-Galactosidase (rhGALC) from a cell culture, wherein a fraction of said cell culture comprising rhGALC is subjected to chromatography on three distinct resins.